V.Y. Institute Of Medical Science Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 8.97 M
as on 03-07-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.21 Cr
as on 03-07-2024
- Satisfied Charges ₹ 47.51 Cr
as on 03-07-2024
- Revenue -18.99%
(FY 2023)
- Profit -92.90%
(FY 2023)
- Ebitda -66.30%
(FY 2023)
- Net Worth 1.60%
(FY 2023)
- Total Assets -2.82%
(FY 2023)
About V.Y. Institute Of Medical Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 8.97 M.
The company currently has active open charges totaling ₹25.21 Cr. The company has closed loans amounting to ₹47.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
Purnima Shridhar, Anil Karnawat, Vishnu Gupta, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110CT2009PTC021067
- Company No.
021067
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at V.Y. Institute Of Medical Science?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Purnima Shridhar  | Director | 19-Feb-2009 | Current |
| Anil Karnawat | Director | 19-Feb-2009 | Current |
| Vishnu Gupta | Director | 19-Feb-2009 | Current |
| Sujata Rajimwale | Director | 19-Feb-2009 | Current |
| Purnendu Saxena | Director | 19-Feb-2009 | Current |
Financial Performance of V.Y. Institute Of Medical Science.
V.Y. Institute Of Medical Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.99% decrease. The company also saw a substantial fall in profitability, with a 92.9% decrease in profit. The company's net worth moved up by a moderate rise of 1.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of V.Y. Institute Of Medical Science?
In 2023, V.Y. Institute Of Medical Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jankalyan Chain Of Blood Banks And Medical ServicesActive 16 years 6 days
Purnendu Saxena is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Aug 2023 | ₹0.50 M | Open |
Hdfc Bank Limited Creation Date: 13 Jun 2023 | ₹7.93 M | Open |
Hdfc Bank Limited Creation Date: 30 Jan 2019 | ₹24.22 Cr | Open |
How Many Employees Work at V.Y. Institute Of Medical Science?
V.Y. Institute Of Medical Science has a workforce of 59 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of V.Y. Institute Of Medical Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V.Y. Institute Of Medical Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
